Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/217320
Title: The role of sodium-glucose cotransporter 2 inhibitors in diabetic nephropathy and non diabetic renal disease in diabetes mellitus type 2 patients
Author: Ibernón, Meritxell
Navarro, Maru
Goma, Montserrat
Tango, Ariel
Rap, Oana
Cabrera, Cristina
Sánchez, Ana
Rodriguez, Neus
Ruiz, Pilar
Keywords: Nefropaties diabètiques
Diabetis no-insulinodependent
Malalties del ronyó
Diabetic nephropathies
Non-insulin-dependent diabetes
Kidney diseases
Issue Date: 1-May-2024
Publisher: Oxford University Press (OUP)
Abstract: Diabetes Mellitus type 2 (DM2) leads to chronic kidney disease in a 30-40% of diabetic patients and it is the major cause of end stage renal disease (ESRD). The clinical course of diabetic kidney disease is very heterogeneous and there is a lack of agreement between clinical parameters and renal histology. Besides, lesions of non-diabetic kidney disease (NDRD) can coexist with lesions of diabetic nephropathy (DN) in two-thirds of kidney biopsies in patients with diabetes.
Note: Comunicació/presentació a: 61st ERA Congress, The European Renal Association, Estocolm, 23-26 maig 2024
Note: Versió postprint del document publicat a: https://doi.org/10.1093/ndt/gfae069.1086
It is part of: Nephrology Dialysis Transplantation, 2024, vol. 39, sup. 1, p. i1768-i1771
URI: https://hdl.handle.net/2445/217320
Related resource: https://doi.org/10.1093/ndt/gfae069.1086
ISSN: 1460-2385
Appears in Collections:Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
gfae069-1086-1626.pdf759.41 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.